MoneyWorks4Me

Cipla informs about business updates

04 Oct 2016 Evaluate

Cipla has submitted a copy of the Notice published on October 04, 2016 in Newspapers informing that the Company intends to apply to the Central Government under section 196 read with Schedule V and other applicable provisions of the Companies Act, 2013 for seeking its approval to the appointment of Umang Vohra as Managing Director of the Company designated as ‘Managing Director and Global Chief Executive Officer’ for a period of five years with effect from September 01, 2016

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..